A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions
Cited by 70
Related Papers
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
|Modern Pathology|2019|46
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
|Cell & Bioscience|2022|16
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
|Communications Biology|2022|16